KnE Life Sciences
ISSN: 2413-0877
The latest conference proceedings on life sciences, medicine and pharmacology.
Factors Affecting the Quality of Life of Epilepsy Patients
Published date: Feb 07 2022
Journal Title: KnE Life Sciences
Issue title: 5th International Conference in Nursing (IVCN)
Pages: 447–459
Authors:
Abstract:
People with epilepsy can lead a normal life, but there are many factors that can affect their quality of life. People with epilepsy may feel anxiety and even depression about their life, which can have an impact on productivity. This study aimed to identify factors affecting the quality of life of epilepsy patients. This study used a cross-sectional design with consecutive sampling and 100 respondents. The analysis used the Chisquare test and logistic regression. The results indicated that the majority of people with epilepsy in the study had a low quality of life (62 people, 62%) and the most influential factor affecting the quality of life was seizure type (odds ratio = 9.716, p = 0.001). Based on the findings, it can be concluded that education level, seizure frequency, type of seizure, stigma and medication adherence are factors that can affect the quality of life in epilepsy patients. Nurses can provide education on the management of seizures to epilepsy patients and their families, to improve the quality of life of people with epilepsy.
Keywords: determinant factors, quality of life, epilepsy
References:
[1] Paschal AM, Rush SE, Sadler T. Factors associated with medication adherence in patients with epilepsy and recommendations for improvement. Epilepsy & Behaviour. 2014;31:346–350.
[2] Espinosa-Jovel C, Toledano R, Aledo-Serrano A, García-Morales I, Gil-Nagel A. Epidemiological profile of epilepsy in low income populations. Seizure. 2018;56:67– 72.
[3] Hawari I, Syeban Z, Lumempouw SF. Low education, more frequent of seizure, more types of therapy, and generalized seizure type decreased quality of life among epileptic patients. Medical Journal of Indonesia. 2007;16(2):101–103.
[4] Vimala PV, Bhutada PS, Patel FR. Therapeutic potential of agomelatine in epilepsy and epileptic complications. Medical Hypotheses. 2014;82(1):105–110.
[5] Xu Y, et al. Frequency and predictors of psychological distress after a diagnosis of epilepsy: A community-based study. Epilepsy & Behaviour. 2017;75:190–195.
[6] Jin K. S1-2. Epilepsy and the autonomic nervous system: Update. Clinical Neurophysiology. 2018;129(5):21–22.
[7] Surges R, von Wrede R, Porschen T, Elger CE. Knowledge of sudden unexpected death in epilepsy (SUDEP) among 372 patients attending a German tertiary epilepsy center. Epilepsy & Behaviour. 2018;80:360–364.
[8] Saadi A, et al. Quality of life in epilepsy in Bhutan. Seizure. 2016;39:44–48.
[9] Radovic NA, Božic K, Ðuric AP, Vodopic S, Radulovic L, Vujisic S. Health-related quality of life in adolescents with epilepsy in Montenegro. Epilepsy & Behaviour. 2017;76:105–109.
[10] Alsaadi T, et al. Potential factors impacting health-related quality of life among patients with epilepsy: Results from the United Arab Emirates. Seizure. 2017;53:13–17.
[11] Lin CY, Saffari M, Koenig HG, Pakpour AH. Effects of religiosity and religious coping on medication adherence and quality of life among people with epilepsy. Epilepsy & Behaviour. 2018;78:45–51.
[12] Tedrus GMAS, Sterca GS, Pereira RB. Physical activity, stigma, and quality of life in patients with epilepsy. Epilepsy & Behaviour. 2017;77:96–98.
[13] Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. Journal of personality assessment. 1988;52(1):30–41.
[14] Fernandes PT et al. Epilepsy stigma perception in an urban area of a limited-resource country. Epilepsy & Behaviour. 2007;11(1):25–32.
[15] Baybas S, Yıldırım Z, Özhan HE, Dirican A, Dirican A. Development and validation of the stigma scale for epilepsy in Turkey. Epilepsy & Behaviour. 2017;67:84–90. [16] Morisky DE, Green LW. Morisky.Pdf. Medical Care. 1986;24:67–74.
[17] Chung K, et al. Quality of life in epilepsy (QOLIE): Insights about epilepsy and support groups from people with epilepsy (San Francisco Bay Area, USA). Epilepsy & Behaviour. 2012;24(2):256–263.
[18] Milovanovic M, Martinovic Z, Toškovic O. Determinants of quality of life in people with epilepsy in Serbia. Epilepsy & Behaviour. 2014;31:160–166.
[19] Bala A, Szantroch M, Gleinert A, Rysz A, Marchel A. Differences in quality of life of women and men with drug-resistant epilepsy in Poland. Epilepsy & Behaviour. 2016;60:94–98.
[20] Manap J, Kassim AC, Hoesni S, Nen S, Idris F, Ghazali F. The purpose of marriage among single Malaysian youth. Procedia-Social and Behavioral Sciences. 2013;82:112–116.
[21] Grant AC, Prus N, Nakhutina L. Factors affecting quality of life in epilepsy in a multiethnic urban population. Epilepsy & Behaviour. 2013;27(2):283–285.
[22] Tsai MH, et al. Etiology of hippocampal sclerosis: Evidence for a predisposing familial morphologic anomaly. Neurology. 2013;81(2):144–149.
[23] Chen HF, Tsai YF, His MS, Chen JS. Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study. Epilepsy & Behaviour. 2016;58:26–32.
[24] Yue L, et al. Determinants of quality of life in people with epilepsy and their gender differences. Epilepsy & Behaviour. 2011;22(4):692–696.
[25] Johnson EL. Seizures and epilepsy. Medical Clinics. North Am. 2019;103(2):309–324.
[26] Tong X, et al. Social support for people with epilepsy in China. Epilepsy & Behaviour. 2016;64:224–232.
[27] Lin CY, Burri A, Fridlund B, Pakpour AH. Female sexual function mediates the effects of medication adherence on quality of life in people with epilepsy. Epilepsy & Behaviour. 2017;67:60–65.
